Vimarsana
Biggest News Aggregation in the World

Eiry Roberts News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eiry Roberts. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eiry Roberts Today - Breaking & Trending Today

New York State Common Retirement Fund Sells 29,456 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) - Vimarsana News

New York State Common Retirement Fund Sells 29,456 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

New York State Common Retirement Fund lessened its stake in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 12.1% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 214,396 shares of the company’s stock after selling 29,456 shares during the period. New York State Common […]

Neurocrine scores surprise win with depression drug - Vimarsana News

Neurocrine scores surprise win with depression drug

BioPharma

Sumitomo Mitsui Trust Holdings Inc. Raises Stock Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) - Vimarsana News

Sumitomo Mitsui Trust Holdings Inc. Raises Stock Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

Sumitomo Mitsui Trust Holdings Inc. increased its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 5.3% during the 4th quarter, Holdings Channel.com reports. The firm owned 243,935 shares of the company’s stock after purchasing an additional 12,382 shares during the period. Sumitomo Mitsui Trust Holdings Inc.’s holdings in Neurocrine Biosciences were worth $32,141,000 […]

Roman Butler Fullerton & Co. Buys New Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) - Vimarsana News

Roman Butler Fullerton & Co. Buys New Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

Roman Butler Fullerton & Co. bought a new stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 8,837 shares of the company’s stock, valued at approximately $1,256,000. A number of other hedge funds […]

Source: wkrb13.com
Baystreet.ca - Neurocrine Gains on Release of Test Results - Vimarsana News

Baystreet.ca - Neurocrine Gains on Release of Test Results

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) shares moved into positive territory Wednesday, on word that the first patient has been randomized for its Phase 2 clinical study to evaluate the efficacy, safety, and tolerability of investigational compound ...